ENSC

Companies
NASDAQ
Ensysce Biosciences Inc.
Health Care
Price Chart
Overview

About ENSC

ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. this abuse is the fastest growing drug problem in the u.s. and it leads to billions in healthcare costs annually. for additional information about ensysce biosciences please visit www.ensysce.com.

Market Cap
$4.1M
Volume
1.1M
Avg. Volume
7.4M
P/E Ratio
-2.6593406
Dividend Yield
0.00%
Employees
6.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.41
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ENSC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ENSC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$4.1M
Volume1.1M
P/E Ratio-2.66
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how ENSC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025